These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors. Cottler-Fox M; Klein HG Arch Pathol Lab Med; 1994 Apr; 118(4):417-20. PubMed ID: 7909429 [TBL] [Abstract][Full Text] [Related]
26. [Hematopoietic growth factors. Current status of therapy]. Hiddemann W Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381 [No Abstract] [Full Text] [Related]
27. Growth factors of the future. Nemunaitis J Leuk Lymphoma; 1993 Mar; 9(4-5):329-36. PubMed ID: 8348068 [TBL] [Abstract][Full Text] [Related]
28. The importance of dose: lymphomas as a model of chemosensitive malignancies. Bronchud MH Eur J Cancer; 1993; 29A Suppl 5():S17-22. PubMed ID: 8260261 [TBL] [Abstract][Full Text] [Related]
29. The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells. Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R Trans Assoc Am Physicians; 1993; 106():134-44. PubMed ID: 7518622 [No Abstract] [Full Text] [Related]
30. [Importance of recombinant proteins in the adjuvant treatment of cancer]. Cheron JM Ann Pharm Fr; 1998; 56(6):241-3. PubMed ID: 9872009 [TBL] [Abstract][Full Text] [Related]
31. In vitro biological activities of the haemopoietic growth factors: implications for their clinical use. Testa NG Acta Haematol; 1991; 86(3):122-7. PubMed ID: 1785226 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of haematopoietic growth factors: defining relevant clinical endpoints in growth factor trials. Linch DC Eur J Cancer; 1994; 30A Suppl 3():S40-3. PubMed ID: 7695958 [TBL] [Abstract][Full Text] [Related]
36. Haemopoietic growth factor and dose intensity in high-grade and intermediate-grade lymphoma. Pettengell R; Crowther D Ann Oncol; 1994; 5 Suppl 2():133-41. PubMed ID: 7911317 [TBL] [Abstract][Full Text] [Related]
37. Hematopoietins: biology, pathophysiology, and potential as therapeutic agents. Mertelsmann R Ann Oncol; 1991 Apr; 2(4):251-63. PubMed ID: 1868020 [No Abstract] [Full Text] [Related]
38. High dose chemotherapy with haemopoietic support for breast cancer. Steward WP Eur J Cancer; 1995; 31A Suppl 7():S21-4. PubMed ID: 8562187 [No Abstract] [Full Text] [Related]
39. The use of haemopoietic growth factors in blood disorders. Hann IM Arch Dis Child; 1994 Dec; 71(6):543-7. PubMed ID: 7726619 [No Abstract] [Full Text] [Related]
40. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients? Mandelli F; Petti MC Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]